Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06779552 · ClinicalTrials.gov registry record
CardioMEMS HF System Coverage with Evidence Development Study
A clinical trial of Heart Failure, sponsored by Abbott Medical Devices.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT06779552 is a study of Heart Failure that is actively recruiting participants, run by Abbott Medical Devices. The registered enrollment target is 1,000 participants, below the 2,047-participant average among 397 other Heart Failure trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06779552, a study of Heart Failure, is actively recruiting participants, sponsored by Abbott Medical Devices.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the CardioMEMS CED Study is to determine if pulmonary artery (PA) pressure-guided heart failure management using the CardioMEMS™ HF System improves long-term health outcomes in heart failure (HF) patients in the real-world setting.
Conditions Studied
Interventions
- DEVICE CardioMEMS HF System
Study Locations (1)
California
- Abbott - Pleasanton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2025-02-07 |
| Est. Completion | 2032-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06779552
The ClinicalTrials.gov registry entry for NCT06779552 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,047-participant average among 397 other Heart Failure trials with a reported enrollment target (51% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which CardioMEMS HF System is the first listed.
NCT06779552 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06779552 about?
NCT06779552 is a clinical study titled "CardioMEMS HF System Coverage with Evidence Development Study". The purpose of the CardioMEMS CED Study is to determine if pulmonary artery (PA) pressure-guided heart failure management using the CardioMEMS™ HF System improves long-term health outcomes in heart failure (HF) patients in the real-world setting.
What is the current status of trial NCT06779552?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2025-02-07. Estimated completion is 2032-03.
What conditions does trial NCT06779552 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT06779552?
The interventions under investigation include: CardioMEMS HF System (DEVICE).
Who is sponsoring clinical trial NCT06779552?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06779552 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.